Roche, Janssen Expand Companion Diagnostic Collaboration
The new agreement allows the companies to collaborate with multiple technologies, including digital pathology and immunoassays.
Paige, Janssen Partner on Bladder Cancer Dx
Janssen's test relies on screening H&E-stained slides, followed by analysis with an internally developed algorithm.
Illumina, Janssen Biotech Form Strategic Partnership to Develop Precision Medicines
The collaboration aims to utilize the sequencing giant's data analytics platforms and lab services to speed up the development of personalized therapies.
Saladax Biomedical Acquires Antipsychotic Drug Testing Patents From Janssen
The portfolio includes 17 patent families resulting in 33 US patents and 296 patents outside of the US.
FDA Approves Janssen's Rybrevant, Guardant360 CDx for EGFR Exon 20-Mutated NSCLC
The agency approved amivantamab for non-small cell lung cancer patients harboring EGFR exon 20 mutations, as detected by Guardant Health's blood-based test.